Billy Price
Family Medicine · Moultrie, GANPI 1841369949
Payments from drug & device makers
Across 330 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$791
- AstraZeneca$470
- AbbVie$437
- Pfizer$387
- Boehringer Ingelheim$364
- GSK$347
- plus $3K from 37 others
What the payments were for
- Food & beverage$5,544100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,544 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 169 | $193,332 |
| TrulicityDulaglutide | 71 | $91,784 |
| JardianceEmpagliflozin | 87 | $86,793 |
| FarxigaDapagliflozin Propanediol | 77 | $60,289 |
| RybelsusSemaglutide | 40 | $59,074 |
| OzempicSemaglutide | 44 | $39,920 |
| LinzessLinaclotide | 58 | $35,659 |
| EliquisApixaban | 31 | $30,650 |
| XareltoRivaroxaban | 34 | $23,880 |
| EntrestoSacubitril/Valsartan | 27 | $21,260 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $18,773 |
| Tresiba Flextouch U-200Insulin Degludec | 27 | $15,656 |
| RexultiBrexpiprazole | 11 | $15,219 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $14,952 |
| Levemir FlexpenInsulin Detemir | 36 | $10,615 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $276 | $285,117240 claims |
| Novo NordiskRybelsus, Ozempic | $791 | $98,99484 claims |
| Boehringer IngelheimJardiance | $364 | $86,79387 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $470 | $79,061107 claims |
| AbbVieLinzess | $437 | $35,65958 claims |
| PfizerEliquis | $387 | $30,65031 claims |
| Johnson & JohnsonXarelto | $93 | $23,88034 claims |
| NovartisEntresto | $64 | $21,26027 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $197 | $15,21911 claims |
| GSKBreo Ellipta | $347 | $10,16423 claims |
| Astellas Pharma US IncMyrbetriq | $33 | $8,59718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Moultrie
- Gary SwartzentruberMoultrie$38K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.